Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BioInvent signs monoclonal antibody manufacturing deal with Cantargia

pharmaceutical-technologyNovember 30, 2020

Tag: BioInvent , Cantargia , CAN10 , antibody

PharmaSources Customer Service